![](https://www.atlanthera.com/wp-content/uploads/2021/09/Bio-Europe-2021-Atlanthera.jpg)
Bio Europe – October 2021
Atlanthera team will attend Bio Europe delivered digitally from October 26th to 28th, 2021! Contact us to plan a meeting [...]
![](https://www.atlanthera.com/wp-content/uploads/2021/01/JPM-2021_Atlanthera.png)
JP MORGAN HEALTHCARE WEEK – January 2021
How great starting this year with JPM Morgan event from January 11th to 15th! [...]
![](https://www.atlanthera.com/wp-content/uploads/2020/04/Bio-Europe-Spring-2020.jpg)
BIO EUROPE SPRING – DIGITALLY DELIVERED – ATLANTHERA
Glad to attend Bio Europe Spring initially planned in Paris and now delivered digitally. Looking forward to fruitful dis [...]
![](https://www.atlanthera.com/wp-content/uploads/2020/04/Publication-ODD-ATA-2019.jpg)
Orphan Drug Designation for our compound 12b80 in Osteosarcoma indication by EMA – Atlanthera
Our team is particularly proud and glad to announce the obtention of Orphan Drug Designation for our compound 12b80 in O [...]
![](https://www.atlanthera.com/wp-content/uploads/2019/10/BIO-Europe-2019.png)
Bio Europe – Hamburg – November 2019
Our team will attend Bio Europe in Hamburg, Germany, from November 11th to 13th. Looking forward to discussing with you [...]
![](https://www.atlanthera.com/wp-content/uploads/2018/05/bio-boston.jpg)
Bio Convention – Boston – June 2018
Our team is delighted about attending BIO International Convention in Boston, MA, from June 4th to 7th. A great opportun [...]
![](https://www.atlanthera.com/wp-content/uploads/2018/03/sheffield-univ.png)
New partnership with Dr Shelly Lawson Team – The University of Sheffield, UK
We are pleased to announce our new collaboration with Dr. Shelly Lawson research team in the department of oncology at t [...]
![](https://www.atlanthera.com/wp-content/uploads/2018/01/Best-Wishes-from-ABS.jpeg)
Best wishes for 2018
Atlanta Group and Atlanthera’s Team wish you success and pleasure in your projects in 2018! We will keep going on our [...]
![](https://www.atlanthera.com/wp-content/uploads/2017/06/Sheffield.jpg)
1st Sheffield Workshop of Translational Research in Bone Sarcoma – June 2017
Meet Atlanthera at the 1st Sheffield Workshop of Translational Research in Bone Sarcoma – 19-20 June 2017 in Sheff [...]
![](https://www.atlanthera.com/wp-content/uploads/2017/04/MATWIN-800x400px.jpg)
Meet2Win 2017
MATWIN organises in Bordeaux on May 11th and 12th 2017 the 3rd edition of MEET2WIN, French Business Convention entirel [...]
![](https://www.atlanthera.com/wp-content/uploads/2017/02/Labiotech-map-Atlanthera.jpg)
Atlanthera listed on LABIOTECH MAP
ATLANTHERA is now part of the 960 European Biotech Companies listed on the Labiotech Map! -Founded in 2011 -Employees: 1 [...]
![fight bone cancer and metastases](https://www.atlanthera.com/wp-content/uploads/2017/01/12b80-bone_cancer.jpg)
Atlanthera veut lever 5 millions pour son traitement contre les cancers osseux
Paru dans le Journal des Entreprises – Par Amandine Dubiez, le 19 janvier 2017 C’est potentiellement un marché [...]
![](https://www.atlanthera.com/wp-content/uploads/2017/01/atlanthera-clinical-phase-osteosarcoma.png)
First clinical test on patients for Atlanthera in 2017
24-01- 2017 Atlanthera is now preparing its first clinical tests on patients for the end of the year 2017. Phase I tests [...]
![](https://www.atlanthera.com/wp-content/uploads/2016/11/Bioeurope-2016-Cologne.jpg)
Meet Atlanthera Team during BIO-Europe in Cologne in November
Atlanthera Team will be participating BIO-Europe event in Cologne, from November 7th to 9th. Visit us on the booth 74, A [...]